Figure 1
TRIB1 R107L mutation identified in DS-related leukemias. (A) Giemsa staining of the case 84 peripheral blood smear diagnosed as AMKL. The image was acquired using a BX40 microscope equipped with a 100×/1.30 NA oil objective (Olympus) and a C-4040 digital camera (Olympus). (B) Fluorescent dye sequencing chromatographs of TRIB1 genotyping by direct sequencing of the case 84 using a cDNA sample as a template. The vertical arrow indicates mixed G and T signals at codon 107. (C) Fluorescent dye sequencing chromatographs of TRIB1 of peripheral blood leukocytes (top) or nail (bottom) in the same case at the complete remission stage. The red arrows indicate that the mutation remains in leukocytes but not in nail. The reverse strand sequences are shown. (D) GATA1 sequence. The start codon that was mutated in AMKL7 is normal in the peripheral blood leukocytes at the remission stage.

TRIB1 R107L mutation identified in DS-related leukemias. (A) Giemsa staining of the case 84 peripheral blood smear diagnosed as AMKL. The image was acquired using a BX40 microscope equipped with a 100×/1.30 NA oil objective (Olympus) and a C-4040 digital camera (Olympus). (B) Fluorescent dye sequencing chromatographs of TRIB1 genotyping by direct sequencing of the case 84 using a cDNA sample as a template. The vertical arrow indicates mixed G and T signals at codon 107. (C) Fluorescent dye sequencing chromatographs of TRIB1 of peripheral blood leukocytes (top) or nail (bottom) in the same case at the complete remission stage. The red arrows indicate that the mutation remains in leukocytes but not in nail. The reverse strand sequences are shown. (D) GATA1 sequence. The start codon that was mutated in AMKL is normal in the peripheral blood leukocytes at the remission stage.

Close Modal

or Create an Account

Close Modal
Close Modal